Apr 24 |
Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
|
Apr 22 |
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
|
Apr 4 |
Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now
|
Apr 3 |
Carisma Therapeutics to Present at Upcoming Conferences
|
Apr 1 |
Carisma to cut 37% of workforce, stock falls 8%
|
Apr 1 |
Carisma Therapeutics GAAP EPS of -$0.52, revenue of $4.29M
|
Apr 1 |
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
|
Apr 1 |
Carisma Therapeutics Announces Changes to its Board of Directors
|
Mar 21 |
Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
|
Feb 28 |
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
|